We now have a chance to stop the most deadly infectious disease — if we act

by Atwal Gawande in The New York Times…In a place with one of the highest TB rates on Earth, I saw that the disease could be stopped with the new tools available. And still more are coming. Clinical trials of five TB vaccines with promising early results are now underway. After decades without major advances, we now have a steady stream of innovations. But they won’t matter unless the world commits to deploying them.

The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence

by James Alwine, et al in The Journal of Virology…Many questions about the origins of SARS-CoV-2 remain unanswered and may never be fully resolved. We cannot currently disprove the lab leak hypothesis. Nevertheless, the lines of evidence needed to validate one hypothesis over another are not epistemically comparable (16). Validating the zoonotic origin is a scientific question that relies on history, epidemiology, and genomic analysis, that when taken together, support a natural spillover as the probable origin.

More in this category